Description
Posiact
Composition: Etoposide IP 20 mg injection for IV administration
Classification: Antineoplastic, Anticancer
Posiact, manufactured by Aprazer Healthcare, offers the first-line treatment for cancer with an accurate, precise dosage form.
Aprazer Healthcare, Trusted Worldwide for High-Quality, Affordable Oncology Medicines
Aprazer Healthcare is the largest oncology medicine manufacturer, exporter, and supplier of 30+ anticancer medicines, following International regulatory guidelines.
- • WHO-GMP certified
- • Assured therapeutic efficacy and quality
- • Available globally in 50+ countries
It is widely used in:
- • Small Cell Lung Cancer
- • Acute Leukemia
- • Bladder Cancer
- • Spread Of Cancer Cells
- • Cancer Of the Testicles
Working of Posiact
It inhibits the topoisomerase enzyme in cancer cells, which is crucial for DNA replication.
- • Stops cancer cell growth.
- • Causes cancer cell death.
Contraindication
- • Not to be used if any previous allergy or hypersensitivity to Etoposide or any excipients.
- • Breastfeeding mothers
- • Pregnant women
Adverse Effects
Chills, fever, dizziness, fainting, fast heartbeat, swelling of face and tongue, breathing troubles.
Serious Side Effects
- • Myelosuppression
- • Gastrointestinal bleeding
- • Painful mouth sores
- • Renal toxicity
- • Hypotension
- • Secondary malignancies
- • Severe infections
- • Cause temporary or permanent infertility
Precautions
Carefully administered in patients with –
- • Hepatic dysfunctions
- • Renal impairment
- • Bleeding disorders
- • Preserve eggs or sperm, may cause infertility
Warnings
To be used under the medical supervision of a physician or an oncologist.
Important Safety and Monitoring Instructions
Regularly monitor:
- • Blood count
- • Renal and hepatic functions
- • Risk of infections
Storage
It should be stored at 2-8 degrees Celsius, protected from light.
Administration Instructions
- • To be administered as a slow IV infusion
- • To be used immediately after reconstitution
